Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Artara Therapeutics Inc. (NQ: TARA)
27.42   UNCHANGED
Streaming Delayed Price  /  Updated: 4:00 PM EDT, Jul 10, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 27.42
Bid (Size) 23.00 (1)
Ask (Size) 33.00 (1)
Prev. Close 27.42
Today's Range 27.42 - 27.42
52wk Range 19.22 - 67.08
Shares Outstanding N/A
Dividend Yield N/A
Performance
YTD
-8.60%
-8.60%
1 Month
-9.68%
-9.68%
3 Month
+19.22%
+19.22%
6 Month
-1.54%
-1.54%
1 Year
-8.60%
-8.60%
Top News
More News
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from GlobeNewswire News Releases
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from GlobeNewswire News Releases
More News
Read More
Protara Therapeutics Receives Fast Track Designation from U.S. FDA for Intravenous Choline Chloride for the Treatment of Intestinal Failure Associated Liver Disease
from GlobeNewswire News Releases
Protara Therapeutics Announces First Quarter 2020 Financial Results and Business Overview
from GlobeNewswire News Releases
ArTara Therapeutics Announces Corporate Name Change to Protara Therapeutics
from GlobeNewswire News Releases
ArTara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from GlobeNewswire News Releases
ArTara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
from GlobeNewswire News Releases
ArTara Therapeutics Appoints Blaine Davis as Chief Financial Officer
from GlobeNewswire News Releases
The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic
category News , ARNA , M&A , and 40 more.
from Benzinga
Stocks That Hit 52-Week Highs On Wednesday
category SNPS , POWI , Health Care Equipment , and 123 more.
from Benzinga
The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study
category Market News , General , REPL , and 43 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.